PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 63: Articles 31001-31500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Endometrial modification in oral contraception with ethinylestradiolsulfonate and norethisterone acetate re. d-norgestrel. [Endometriumveranderungen bei oraler hormonaler Kontrazeption mit Athinylostradiolsulfonat und Norathisteronazetat bzw. d-Norgestrel.]
  2. Endoscopic contraception: a look at three methods.
  3. Enzyme induction as a possible cause of increased serum-triglycerides after oral contraceptives.
  4. An epidemiologic view of family planning behavior.
  5. An epidemiological study of the haemostatic and other effects of oral contraceptives.
  6. Erythema nodosum and oral contraceptives.
  7. Erythema nodosum secondary to oral contraceptive usage: a case report.
  8. An estimate of the direct impact of family planning programs on the birth rate of Colombia.
  9. Estrogen-containing oral contraceptive agents: a basis for their thrombogenicity.
  10. The ethics of medical supervision in family planning programs: too little or too much??
  11. Etiologies of lupus erythematosus. A little known etiology: oral contraceptives. [Etiologies de l'erytheme noueux--une etiologie peu connue: les oestro-progestatifs.]
  12. Evaluating carcinogenicity of oral contraceptives. (Letter to the editor)
  13. An evaluation in rats of nutritional status and reproduction performance post oral contraceptive therapy.
  14. An evaluation of activities of the Center for Disease Control Family Planning Evaluation Division (AID/RSSA-PIO/T 932-978-2-3267514)
  15. Evaluation of an oral contraceptive containing only progestogen.
  16. Evaluation of emotional reactions to oral contraceptive use.
  17. Evaluation of family planning programmes: an example from Botswana.
  18. Evaluation of sex chromatin number in newborn infants born to mothers who have taken oral contraceptives. [Oralis fogamzasgatlok szedeset koveto terhessegbol szarmazo ujszulottek nemi chromatin szamanak ertekelese.]
  19. Evaluation of the Family Planning Project, 615-11-580-161, USAID/KENYA, Nairobi, Kenya.
  20. An evaluation of the health-centre as a family planning unit.
  21. Evaluation of Ypsilon, a new intrauterine contraceptive device, in Brazil (study of 2162 cases)
  22. Evaluation research on family planning communication.
  23. Evidence of altered estrogen-progestin metabolism in hypertensive oral contraceptive users. (Abstract only)
  24. Evolution of the knowledge about and use of contraceptive methods among married women in the Dutch-speaking community of Belgium, 1966-1977: preliminary results of NEGO-III. [Evolutie van de kennis en van het gubruik van anticonceptionele methoden bij de gehuwde vrouwen van de Nederlandse culuurgemeenschap in Belgie, 1966-1977: Eerste resultaten van NEGO-III.]
  25. Exaggeration of experimental hypertension in rats by contraceptive steroids (Enovid)
  26. Expanding availability of modern contraceptives to traditional rural peoples in Latin America: can Parteras Empiricas provide community distribution?
  27. Expanding the interpersonal communication base for family planning: a study in co-ordination with other agencies.
  28. Expenditures for organized family planning services in the United States: 1974.
  29. Experience in Mexico with intrauterine hormone contraception. [Experiencia en Mexico con el sistema anticonceptivo hormonal intrauterino.]
  30. Experience with norethisterone enanthate as injectable contraceptive.
  31. Experiences with the modern intrauterine devices Cu-7 and Cu-T (author's transl) [Erfahrungen mit modernen Intrauterine Contraceptive Devices Cu-7 und Cu-T.]
  32. Experimental design: parenteral contraceptives in the rhesus monkey. Introduction, method and results. [Diseno experimental: los contraceptivos parenterales en mona rhesus. Introduccion, metodo y resultados.]
  33. Experimental model to study hypertriglyceridaemia induced by steroid contraceptives. (Abstract only)
  34. Exposure to family planning programme.
  35. Extending family planning services to the mentally retarded.
  36. Extending skills in family planning nursing: psychosexual seminar training.
  37. The extent of the practice of family planning among Africans in Mashonaland.
  38. Extramedical distribution of oral contraceptives. Review of the literature. [La distribution extra-medicale du contraceptif oral: revue de la litterature.]
  39. Eye complications during oral contraceptive treatment. [Complications oculaires au cours du traitement contraceptif par voie orale.]
  40. Factors affecting intrauterine contraceptive device performance: 1. Endometrial cavity length.
  41. Factors opposed to contraceptive programs.
  42. Factors related to the use of family planning services of low-income teen-age mothers.
  43. Facts and opinion; adolescent contraceptive counseling.
  44. Failures of contraceptive practice.
  45. Familial benign recurrent intrahepatic cholestasia: interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives?
  46. (Familial benign recurrent intrahepatic cholestasis.) Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives?
  47. The family and family planning in Kwun Tong: an overview of findings.
  48. Family and planning in India.
  49. Family formation and birth control: behavior and attitudes.
  50. Family planning (Editorial) [Gesinsbeplanning.]
  51. Family planning - possibilities and limitations. [Familienplanung - Moglichkeiten und Grenzen.]
  52. Family planning among the Maranaos.
  53. Family planning among the Muslims: the Koran and population control.
  54. Family planning and family size determination: the evidence from seven Latin American cities.
  55. Family planning and fertility decline in Colombia, 1964-1975.
  56. Family planning and husband-wife relationships in Turkey.
  57. Family planning and socioeconomic development have substantial and equal effect on fertility.
  58. Family planning and the teenager.
  59. Family planning and workers.
  60. The family planning approach.
  61. Family planning as a part of heath care. [Familieplanleggning som en del av det forebyggende helsearbeid.]
  62. Family planning as public policy.
  63. Family planning during psychiatric hospitalization.
  64. Family planning education and health care delivery in the People's Republic of China: implications for educational alternatives.
  65. Family planning education for listeners in South Asia.
  66. Family planning effectiveness.
  67. The family planning fieldworkers in the subdistrict of Serpong.
  68. Family planning for the mentally handicapped. (Letter to the editor)
  69. Family planning in a Chinese-American population.
  70. Family planning in a hospital clinic.
  71. Family planning in Bohol, 1975: characteristics of users of four family planning methods.
  72. Family planning in China and south-east Asia. An interview with Dr. Yutaka Moriyama.
  73. Family planning in China.
  74. Family planning in China.
  75. Family planning in China: The largest community program in the world. [Planificacion familiar en China: El programa comunitario mas grande del mundo.]
  76. Family planning in Cuba, 1974.
  77. Family planning in hospitals.
  78. Family planning in hospitals. (Letter to the editor)
  79. Family planning in India. [Indiens Familienplanung.]
  80. Family planning in India: a case study of Karnataka.
  81. Family planning in indigenous areas of Guatemala.
  82. Family planning in Japan.
  83. Family planning in Kenya and problems of drop-outs.
  84. Family planning in Pakistan: an analysis of some factors constraining use.
  85. Family planning in rural areas.
  86. Family planning in social work curriculum: a curriculum development in social work education.
  87. Family planning in South Africa: a review.
  88. Family planning in the hospital service.
  89. Family planning in the hospital service. (Letter to the editor)
  90. Family planning in the industrial sector and Asian response: a bibliography reviewed.
  91. Family planning in the People's Republic of China.
  92. Family planning in the rural areas of Costa Rica.
  93. Family planning in Tunisia. [La planification familiale en Tunisie.]
  94. Family planning instruction in medical schools: content, type training, and hours of instruction.
  95. Family planning measure -- their merits and demerits.
  96. The Family Planning Model Clinic and Research Center evolution of method acceptance during the first two years, 1974-1976.
  97. Family planning needs and services in nonmetropolitan areas.
  98. Family planning not against any religion.
  99. The family planning nurse practitioner: concepts and results of training.
  100. Family planning opinion leadership in Korea, 1971.
  101. The family planning policy of Tunisia. [La Politique Du Planning Familial En Tunisie.]
  102. Family planning program administration in Thailand: systems, issues and problems.
  103. Family planning program effects on the fertility of low-income U.S. women.
  104. A family planning program for the Honduran campesino.
  105. Family planning program operation and achievements.
  106. Family planning program said to cut infant deaths.
  107. Family planning programme in India.
  108. Family planning programme in rural Mirzapur.
  109. Family planning programs in Asia: an overview of management problems and issues.
  110. Family planning programs in industrial companies.
  111. Family planning programs: some recommended tabulations and their use. [Programas de planificacion de la familia: algunas tabulaciones recomendables y su utilizacion.]
  112. Family planning rumors in Korean rural areas.
  113. Family planning scholarships made available in Maryland.
  114. Family planning service statistics: annual report 1975.
  115. Family planning services by traditional birth attendants.
  116. Family planning services for persons handicapped by mental retardation.
  117. Family planning services in the home.
  118. Family planning statistics. [Statistiques de planning familial.]
  119. Family planning status and dissemination of contraceptive methods in urban slum areas.
  120. Family planning surveys and studies: current status and future needs.
  121. Family planning through rural banking.
  122. Family planning-DLGCD style.
  123. Family Planning. [Editorial.]
  124. Family planning. [Planowanie rodziny.]
  125. Family planning: general principles and traditional methods.
  126. Family planning: still a controversial subject. [La planification familiale: un suget encore controverse.]
  127. Fertility and contraceptive practice: Bogota, 1964-74.
  128. Fertility and family planning among blacks in South Africa: 1974.
  129. Fertility and family planning among nomads. [Fecondite et planning familial parmi les nomades.]
  130. Fertility and family planning in Europe around 1970: a comparative study of twelve national surveys.
  131. Fertility and family planning in Mojolama.
  132. Fertility and family planning in urban Lucknow; a bench mark survey.
  133. Fertility and family planning in Yugoslavia.
  134. Fertility and family planning practice in the project area: preliminary findings from the longitudinal study.
  135. Fertility and family planning practice in West Bengal villages (based on survey data from villages of Barasat, 1976)
  136. Fertility before and after first contraceptive use and before and after acceptance at family planning clinics.
  137. Fertility impact of family planning programs in the context of social change and economic development.
  138. Fertility patterns after discontinuation of use of oral contraceptives.
  139. Fertility, child mortality and family planning in the rural areas of Uttar Pradesh, India.
  140. Fertility, family planning and desire for children: four district baseline survey report no. 1.
  141. Fertility-rates after oral contraceptives. (Letter to the editor)
  142. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
  143. Field dependence-independence, internal-external locus of control, and implementation of family-planning goals.
  144. The Fifth Five Year Plan: health, family planning and nutrition.
  145. Final report on the study of the use of a vaginal contraceptive, conceptrol cream, as a prophylaxis agent against gonorrhea.
  146. Financial management of population/family planning programmes. (A report of the IGCC Regional Workshop/Seminar, Manila, Phili.
  147. Financial resources and management of the International Planned Parenthood Federation.
  148. First practical experiences with a new hormonal contraceptive, Gravistat-Jenapharm. [Erste Erfahrungen mit einem neuen hormonalen Kontrazeptivum: Gravistat-Jenapharm.]
  149. First round of the household survey to evaluate the impact and effectiveness of the Community-Based Family Planning Services program in Thailand.
  150. The first three months of free contraception in a market-town group practice.
  151. A five-year plan for family planning services and population research: fifth progress report to the Congress of the United States, Pursuant to Section 5, Public Law 91-572.
  152. Focal nodular hyperplasia of the liver during oral contraceptive treatment (Letter) [Hyperplasies nodulaires focales du foie observees au cours de traitements estro-progestatifs.]
  153. Focus on the analysis of menstrual patterns in the critical evaluation of contraceptives. [Enfoque al analisis de patrones menstruales en la evaluacion critica de anticonceptivos.]
  154. Foetal indications of family planning.
  155. Folate depletion and contraceptive steroids: 1. Diet and previous use of oral contraceptives as determinants of folate status in pregnancy. 2. Negative effect of contraceptive steroids on folate depletion in rats.
  156. Follow-up study of oral contraceptive acceptors in Howrah District in India.
  157. Four years overall experience with a new low estrogen - low progestogen oral contraceptive.
  158. Freer dispensing of oral contraceptives. (Letter)
  159. From incidental to planned parenthood.
  160. Funding of contraceptive research.
  161. A future perspective of family planning performance in India: (1975-1985)
  162. Gambia family planning information and education quarterly fieldwork report - April-June, 1976.
  163. Gambia family planning information and education quarterly report from January-March 1976.
  164. Gender of offspring after oral-contraceptive use.
  165. General principles of contraceptive technology.
  166. Ghana: Danfa comprehensive rural health and family planning project.
  167. Government and community join forces for family planning.
  168. Government response to contraceptive and cosmetic health risks.
  169. Greater Bombay experiment in family planning.
  170. Guidelines for the evaluation of training of family planning programme administrators.
  171. Gynaecological cytology in family planning services in Nigeria.
  172. Gynecologic infection in sterility retrospective study: 302 patients family planning center Sao Paulo, 1976.
  173. Gynetrol Mikrogen. Oral contraceptive with low estrogen content. [Gynatrol, Mikrogyn. P-pille med lavt ostrogenindhold.]
  174. The haemolytic uraemic syndrome and oral contraceptives.
  175. Hazards of oral contraceptives to future generations. (Letter)
  176. Health and family planning. Reconsidering the evolution of ideas. [Sante et planification familiale. Reflexious sur l'evolution des idees.]
  177. Health and family planning: years of achievement.
  178. Hearing levels according to use of oral contraceptives in 5,449 women.
  179. Heart disease and contraception. [Cardiopathies et contraception.]
  180. Hemoperitoneum due to rupture of a benign tumor of the liver in women taking oral contraceptives - 2 cases. [Hemoperitoine par rupture de tumeur benigne du foie chez des femmes prenant des contraceptifs oraux.]
  181. Hemostasis and oral contraception. [Hemostase et contraception orale.]
  182. Hepatic adenoma and oral contraception. [Adenome hepatique et contraception orale.]
  183. Hepatic adenoma associated with oral contraceptive use.
  184. Hepatic adenoma: a possible complication of oral contraceptive therapy.
  185. Hepatic adenomas and oral contraceptives. [Adenomas hepaticos y anticonceptivos orales.]
  186. Hepatic cell adenomas, peliosis and oral contraceptives. [Nodules du foie, peliose et pilule. Anatome pathologique.]
  187. Hepatic changes in young women ingesting contraceptive steroids.
  188. Hepatic complications due to oral contraceptives. [Complications hepatiques des contraceptifs oraux.]
  189. Hepatic tumor, hemoperitoneum and oral contraceptives.
  190. Hepatic tumors and oral contraception. Gynecologic point of view. [Les tumeurs hepatiques et la contraception orale. Aspect gynecologique.]
  191. Hepatocellular adenoma and oral contraceptives.
  192. Hepatocellular carcinoma and oral contraceptives. (Letter to the editor)
  193. Heterogeneity of renin substrate in human plasma: effect of pregnancy and oral contraceptives (39536)
  194. The hilot in transition: integrating family planning and birth attending.
  195. Histologic changes associated with oral contraceptive usage.
  196. Histology of the endometrium in long-term use of a sequential oral contraceptive.
  197. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
  198. Honduras: Family planning and functional education.
  199. Hormonal changes in women taking Femulen for contraceptive purposes. [Gormonalnye izmeneniya u zhenschin vo vremya priema Femulena s kontratseptivnoi tselyu.]
  200. Hormonal contraception - oral and injectable.
  201. Hormonal contraception - thromboembolic disorders and surgical risk. [Hormonale Kontrazeption-Thromboembolie und Operationsrisiko.]
  202. Hormonal contraception in adolescents. [Untersuchungen zur hormonalen Kontrazeption bei Jugendlichen.]
  203. Hormonal contraception. [Hormonale Kontrazeption.]
  204. Hormonal contraception: pharmacotherapy of the healthy woman. [Hormonale Kontrazeption: Pharmakotherapie der gesunden Frau.]
  205. Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent. [Anticoncepcion hormonal, insuficiencia venosa periferica y el uso de un flebodinamico.]
  206. Hormonal contraceptives.
  207. Hormonal profiles and variations of the EEG and of performances in psychological tests in women with spontaneous menstrual cycles and under oral contraceptives.
  208. Hospital counseling in Khartoum: a study of factors affecting contraceptive acceptance after abortion.
  209. Household contraceptive distribution program in rural Bangladesh -- six month's experience.
  210. Household contraceptive distribution: preliminary results for Euiryong, Korea.
  211. How best to use oral contraceptives and IUDs.
  212. How do women judge their knowledge of contraception? A study of 386 women from a psychological-sociological viewpoint. [Wie beurteilen Frauen ihr Wissen uber Kontrazeption? Eine Untersuchung an 386 Frauen unter psychologisch-soziologischen Aspekten.]
  213. Human reproduction. Physiology, population, and family planning. Volume 1: Physiology.
  214. Human reproduction. Physiology, population, and family planning. Volume 2: Population.
  215. Human reproduction. Physiology, population, and family planning. Volume 3: Family planning.
  216. Human rights aspects of Beyond Family Planning Measure.
  217. Human sexuality and family planning. [Sexualidad humana y planificacion familiar.]
  218. Humanistic family planning.

     

  219. Hypertension detected in young black women by routine screening in a family planning clinic.
  220. Hypertension in family practice. Pt. 6. The risk of hypertension and thrombosis during oral contraceptive use. [Hypertensie in de huisartsenpraktijk. Dec/6. Het risico van hypertensie en trombose gedurende de inname van orale contraceptieven.]
  221. Hypertension induced by oral contraceptives. [Klinik der Hypertonie unter kontrazeptiven Steroiden.]
  222. Ileo-colic Crohn's disease after use of an oral contraceptive. [Maladie de Crohn ileo-colique apres emploi d'un contraceptif oral.]
  223. The impact of a family planning clinic in rural Jamaica.
  224. Impact of a rural family planning program in Ishan, Nigeria, 1969-72.
  225. Impact of abortion hazards on family planning programme.
  226. Impact of communication on the growth of population (1961-71) and family planning activities in the rural Patna District. (A pilot study of Phulwari Block)
  227. The impact of family planning radio lessons on the knowledge and practice of family planning among women of nine clinics of the Population and Family National Council: final report. [Impacto de la escuela radiofonoca de educacion familiar sobre el conocimiento y practica de la planificacion familiar de las usuarias de nueve clinicas del Consejo Nacional de Poblacion y Familia: informe final.]
  228. The impact of health education on acceptance of family planning methods for spacing by lower socio-economic primiparous urban women.
  229. Impact of inter-spouse communication on family planning adoption.
  230. The impact of liberalized abortion legislation on contraceptive practice in Denmark.
  231. Impact of the family planning program on fertility in Mauritius.
  232. Implications for the development of a clinically useful contraceptive.
  233. Improving family planning services for teenagers.
  234. Improving family planning services for teenagers: executive summary.
  235. In-hospital contraceptive program.
  236. Incidence of abortion and contraceptive patterns during 1968-1974. [Aborthyppighed og svangerskabsforebyggelse belyst for arene 1968-1974.]
  237. Incidence of bacteriuria in connection with hormonal contraception. [Bakteriuriehaufigkeit bei hormonaler Antikonzeption.]
  238. Incidence of infections associated with the intrauterine contraceptive device in an isolated community.
  239. Increasing youth programmes in family planning.
  240. India. (Population education and family planning)
  241. India: a family planning fiasco.
  242. India: Rural family planning program, Allahabad.
  243. Indian outlook on family planning.
  244. The Indonesia family planning program: basic strategies.
  245. Induced abortion and contraceptive practice: an experience in Taiwan.
  246. Induction of microsomal drug metabolizing enzymes by oral contraceptives in protein-malnourished rats.
  247. Influence of an oral contraceptive ethinylestradiol/d-norgestrel on growth hormone and insulin secretion. [Einfluss eines Ovulationshemmers - Aethinyloestradiol/d-norgestrel - auf Wachstumshormon- und Insulinsekretion.]
  248. Influence of certain drugs on the action of contraceptive pills. [Influence de certains medicaments sur l'action des pilules contraceptives.]
  249. The influence of hormonal contraceptives on the renin-angiotensin-aldosterone system. [Vliyanie gormonalnykh protivozachatochnykh sredstv na sistemu renin-angiotenzin-aldosteron.]
  250. Influence of oral contraception on thrombocyte function. 1st report: number of platelets, platelet spreading and aggregation with the use of hormonal contraceptives. [Beeinflussung der Thrombozytenfunktion durch hormonelle Kontrazeption. 1. Mitteilung: Anzahl der Thrombozyten, Thrombozytenausbreitung, und Plaettchenaggregation unter hormeneller Kontrazeption.]
  251. Influence of oral contraceptives on blood clotting. [Utjecaj oralnih kontraceptiva na zgrusavanje krvi.]
  252. Influence of oral contraceptives on folic acid level. [Beeinflussen orale Kontrazeptiva den Folsaure-Spiegel im Plasma?]
  253. Influence of oral contraceptives on thyroid hormone levels, blood coagulation and ceruloplasmin (Abstract only) [Die Beeinflussung von Schilddruesenhormonspiegel, Blutgerunnung und Coeruloplasmin durch Ovulationshemmer.]
  254. Influence of oral contraceptives, pyridoxine (Vitamin B6), and tryptophan on carbohydrate metabolism.
  255. Influence of the oral contraceptive, mestranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
  256. Inhibition of hepatic demethylation by oral contraceptives: analysis by breath test. [Hemmung der hepatischen Demethylierung durch orale Antikonzeptiva: Analyse mit Atemtest.]
  257. Inhibition of hepatic lactate production by contraceptive steroids in glucose-fed swine. (Abstract only)
  258. Inhibition of hepatic metabolism of diemethylaminoantipyrine (DAP) by oral contraceptive steroids in humans. (Abstract only)
  259. Inhibition of ovulation by a synthetic contraceptive tetrapeptide. (Abstract only)
  260. Inhibitory effect of acetylsalicylic acid on human platelet function in normal volunteers and in women using a combined oral contraceptive regime.
  261. Injectable contraceptives in rural Bangladesh: a preliminary report.
  262. Innovative family planning field strategies.
  263. Instant Sagot Sa family planning - November 1974-June 1975; J.
  264. An integrated course for primary health care workers with family planning, maternal and child health and nutrition as important components.
  265. Integrated family planning programs in the Western Hemisphere.
  266. Integrated family planning projects.
  267. Integrated role of nutrition in medicine-promotion of health and family planning and prevention of illness.
  268. Integrating family planning education: the realistic alternative.
  269. Integrating health and family planning services.
  270. Integration of family planning and maternal and child health in rural West Africa.
  271. Integration of nutrition with family planning programme.
  272. Integration of the traditional midwives into the Tunisian Family Planning Programme.
  273. Intensive family planning information and service delivery campaign: a short evaluation in Comilla.
  274. Interactions between oral contraceptives and other drugs: a review.
  275. Interactions with oral contraceptives.
  276. Interactive effects of induced abortion, inter-pregnancy interval and contraceptive use on subsequent pregnancy outcome. (Abstract only)
  277. International cooperation in family planning.
  278. International Fairfield Study on the effectiveness of the sympto-thermal method of family planning. Canadian results compared to world results. [Etude internationale Fairfield sur l'efficacite de la methode sympto-thermique de regulation des naissances. Resultats canadiens compares aux resultats globaux.]
  279. Interregional consultation meeting of the operational integration of nutrition and family planning programmes, New Delhi, Oct. 1976: draft report.
  280. Interstitial pregnancy and the arias-stella phenomenon with contraceptive coil in situ. [Interstitsialna bremennost i Fenomen na arias-stella pri antikonsteptsionna spirala in situ.]
  281. Intestinal complications during the use of oral contraceptives. [Les accidents intestinaux au cours de l'emploi des contraceptifs oraux.]
  282. Intrauterine contraception in adolescent women.
  283. Intrauterine contraception with the copper T 200 and the Dalkon Shield in nulligravid women.
  284. Intrauterine contraception. [O vnutrimatochnoi kontratseptsii.]
  285. The intrauterine contraceptive device and tubal pregnancy in a small community hospital.
  286. Intrauterine contraceptive devices with copper, the combined multiload copper IUD (MLCu 250)
  287. Intrauterine contraceptive devices.
  288. Intrauterine device increases the fibrinolytic activity of the rat endometrium at deciduation, a new aspect of its contraceptive effect.
  289. The intrauterine progesterone contraceptive system.
  290. Intrauterine progesterone-releasing contraceptive systems.
  291. Intravaginal collagen sponge contraceptive device: status, December, 1976.
  292. Intravaginal contraception with the synthetic progestin, R2323.
  293. Introduction (to biochemical contraception)
  294. Introduction (to community-based distribution of contraceptives survey)
  295. Introduction (to part 2, the women using the domiciliary family planning service)
  296. Introduction to the problems posed by contraception in North African and Portuguese immigrant families. [Introduction aux problemes poses par la contraception dans les familles immigrees Nord-Africaines et Portugaises.]
  297. Investigation of Danazol as a contraceptive agent.
  298. An investigation of the effects of the intrauterine contraceptive device based on a longitudinal study of a self-selected sample of Barbadian women.
  299. Is absorption of oral contraceptives affected by intestinal bypass for obesity?
  300. The IUD as a post-abortion contraceptive. [El dispositivo intrauterino como anticonceptivo post-aborto.]
  301. Japanese experience in distribution of contraceptives.
  302. Jaundice of oral contraceptives. [Les icteres des contraceptifs oraux.]
  303. KAP of family planning.
  304. Keynote address. (Family planning education)
  305. Knowledge and acceptance of postabortion contraceptive methods. [Conhecimento e aceitacao de metodos anticoncepcionais apos abortamento.]
  306. Knowledge and practice of family planning among women who utilize abortion.
  307. Knowledge before power: a guide to DC area birth control clinics.
  308. Knowledge, use and effectiveness of contraception in Belgium.
  309. Lack of influence of oral contraceptives on serum folate, hematologic values, and uterine cervical cytology.
  310. Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain.
  311. Lack of interest in family planning information among the urban people of Surakarta.
  312. Lactation as a contraceptive method.
  313. Lactation, fertility, and contraception.
  314. Lactation, fertility, and contraception. (Letter to the editor)
  315. Land development - a beyond family planning measure.
  316. Laparoscopic techniques family planning programme Pakistan, 18-31 December 1975 (Assignment Report)
  317. The legacy of S.S. Sarkar: casting an incisive look at an established notion. Is there a case for family planning as an instrument for social progress?
  318. Legal abortion: 1000 women. Data concerning contraception, age and obstetric history. [Abortus provocatus legalis: 1.000 kvinder. Data on antikonception, older og obstetrisk anamnese.]
  319. Legal abortion: Abortion as a form of contraception? A prospective study of 608 women applying for abortion. [Abortus provocatus legalis: Abort som antikonception? En prospektiv undersogelse blandt 608 abortsogende kvinder.]
  320. Legal and policy aspects of community based distribution of oral contraceptives in South East Asia.
  321. Legal aspects of community based distribution of contraceptives, sterilisation and post conceptive regulation.
  322. Legal aspects of community-based distribution of contraceptives in ESEAO region.
  323. Legal handbook on contraception, voluntary sterilization and abortion.
  324. The legality of purely contraceptive sterilization.
  325. The LEM device in an immediate postpartum contraception program.
  326. Liability for failure of birth control methods.
  327. Life table methodology applied to the evaluation of contraception.
  328. Lipid changes induced by oral contraceptives. [Modifications lipidiques induites par les contraceptifis oraux.]
  329. A listing of Ford Foundation-supported institutions in the U.S. and Europe offering fellowships for training and research in demography and family planning.
  330. Lithogenic bile: a study in women taking oral contraceptives. (Abstract only)
  331. Liver cell tumors and peliosis hepatis as a result of oral contraceptives. [Tumeurs du foie et peliose hepatique associees a la prise de contraceptifs oraux.]
  332. Liver lesions due to long term use of anabolic steroids or oral contraceptives. [Leverafvijkingen na langdurig gebruik van anbole steroiden of orale anticonceptiva.]
  333. Liver lesions due to long-term use of anabolic steroids and oral contraceptives (author's transl) [Leverafwijkingen bij langdurig gebruik van anabole steroide en orale anticonceptiva.]
  334. Liver tumors and oral contraceptives.
  335. Liver tumours and oral contraceptives. (Letter)
  336. Liver-cell adenomas and oral contraceptives [Letter]
  337. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  338. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  339. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  340. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  341. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  342. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  343. Liver-cell adenomas and oral contraceptives. (Letter to the editor)
  344. Liver-cell adenomas associated with use of oral contraceptives.
  345. Local chemical contraception. Results after four years of experience. [La contraception chimique locale. Resultats apres quatre ans d'experimentation.]
  346. Long-acting injectable contraceptives.
  347. Long-acting injectable contraceptives.
  348. Long-acting steroid contraceptive formulations.
  349. Long-term contraception with norethindrone subcutaneous capsules.
  350. A long-term follow-up study of women using different methods of contraception - an interim report.
  351. Low oestrogen oral contraceptives.
  352. Low-oestrogen oral contraceptives. (letter)
  353. Lower esophageal sphincter pressure in women using sequential oral contraceptives.
  354. Luteinizing hormone and progesterone in women under postcoital contraception with d-norgestrel.
  355. Luteinizing hormone secretion in patients presenting with post-oral contraceptive amenorrhea: evidence for a hypothalamic feedback abnormality.
  356. Lymphocyte transformation in newborns, normal women and those who had used oral contraceptives.
  357. Magdamayan: strategy for a rural family planning program (the FPOP model)
  358. Maintenance of lactation by means of continuous low-dose progestogen given post-partum as a contraceptive.
  359. Male contraception - an overview.
  360. Male contraception without prescription: the condom and coitus interruptus.
  361. Male contraception without prescription: a reevaluation of the condom and coitus interruptus.
  362. Male methods of contraception.

     

  363. Management and outcome of pregnancies associated with the copper T intrauterine contraceptive device.
  364. Management issues in beyond Family planning policies.
  365. Management issues in family planning program operations: knowledge and action.
  366. Management issues in the organization and delivery of family planning services: international perspective.
  367. Management of family planning clinics: organizational characteristics and productivity.
  368. A management planning model for the delivery of family planning services.
  369. Management problems of family planning programs. Final Report of the 7th Seminar-Workshop, Washington, D.C., September 20-October 29, 1976.
  370. The manufacture of steroidal contraceptives: technical versus political aspects.
  371. Margaret Sanger, the ''Woman Rebel'' and the rise of the birth control movement in the United States.
  372. Marital and sex counseling in a family planning center. [Problematique conjugale et sexologique dans un centre de planning familial.]
  373. Mass communication and family planning.
  374. Massive colonic bleeding and oral contraceptive "pills."
  375. Maternal midtrimester sepsis in association with the intrauterine contraceptive device: early histopathologic findings.
  376. Maximizing availability of contraceptives through household distribution.
  377. Measurements of serum folic acid levels in students receiving contraceptive agents. [Messung des Serumfolatspiegels, n-methyl-THF, bei studenten unter beruk sichtigung einer medikation mit kontrazeptiva.]
  378. Mechanism of action of intrauterine contraceptive devices.
  379. Medical backup for the CBFPS (Community Based Family Planning Services) pilot project and PPAT-CD (Planned Parenthood Association of Thailand) project.
  380. Medical, psychological, and social aspects of contraceptive choice.
  381. Medical-social evaluation of family planning practice in Dakar, based on 354 cases in intrauterine contraception during the course of 27 months--July 1973 - October 1975. [Evaluation medico-social d'une action de planification familiale a Dakar, portant sur 354 case de contraception intra-uterine pendant 27 mois--Juillet 1973-Octobre 1975.]
  382. Medico-legal aspects of family planning in Kenya.
  383. Medicolegal aspects of contraception. [Aspects medico-legaux de la contraception.]
  384. The medroxyprogesterone acetate intravaginal silastic ring as a contraceptive.
  385. Megaloblastic anaemia due to pyridoxine deficiency associated with prolonged ingestion of an oestrogen-containing oral contraceptive.
  386. Menstrual and child-bearing function of women who used mechanical and hormonal contraceptives. [O menstrualnoi i detorodnoi zhenschin, primenyavshikh mekhanicheskie i gormonalnie kontratseptiv.]
  387. Menstrual regulation as a treatment of secondary amenorrhea in contraceptive users.
  388. Mesenteric venous thrombosis associated with oral contraceptives: a case report.
  389. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration.
  390. Metabolism of oral contraceptive drugs: the accumulation and identity of metabolites of norethindrone (NOR) and mestranol (MEST). (Abstract Only)
  391. Methionine metabolism and Vitamin B6 status in women using oral contraceptives. (Abstract only)
  392. Methodology of the radio school of family planning. [Metodologia de la escuela radiofonica de educacion familiar.]
  393. Methods for the evaluation of changes in the menstrual cycle induced by hormonal contraceptives.
  394. Microdose progestogens for contraception.
  395. Mid-year report of activities for 1976: national program of family planning and sex education. [Informe semestral de actividades 1976: programa nacional de planificacion familiar y educacion sexual.]
  396. Migraine and oral contraceptives.
  397. The mobile clinic in relation to the family planning programme: an experimental study in two desa of the Kecamatan Serpong, West Java.
  398. Model building in family planning research.
  399. A model curriculum for training of family planning administrators based on findings from an organizational study of family planning programme performance.
  400. The model family planning project in Isfahan, Iran.
  401. Modelling and control of birth and death processes.
  402. Modernism and contraceptive use in Colombia.
  403. Modification of striatal dopamine levels by steroid contraceptive drugs in mice and rats.
  404. Molecular biology and oral contraception.
  405. Monthly single injection of contraceptives in Czechoslovakia. [Tschechoslowakisches Injektionskontrazeptivum, einmal im Monat zu verabreichen.]
  406. More pre-teens want birth control advice.
  407. Mortality, fertility, and contraceptive use in Shanghai, the People's Republic of China.
  408. Motivation and family planning: incentives and disincentives in the delivery system.
  409. Motivation of sterilization patients: implications for family planning education programs.
  410. Motivations for the use of birth control: evidence from West Africa.
  411. Motivations, roles and family planning of women.
  412. MPA, 6 alpha-methyl-17 alpha-hydroxyprogesterone, 25 mg plus estradiol cipionate 5 mg as a low-dose contraceptive administered parenterally on a monthly schedule. [AMP, 6 alfa-metil-17 alfa-hidroxiprogesterona 25 mg mas cipionato de estradiol 5 mg, como anticonceptivo de aplicacion parenteral mensual en dosis baja.]
  413. Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
  414. Myocardial infarct in young women and steroid contraception. [Infarkt myokardu u mladych zen a steroidni antikoncepce.]
  415. Myocardial infarction in younger women. Associated clinical features and relationship to use of oral contraceptive drugs.
  416. Naphthylamidase isoenzymes in serum during treatment with oral contraceptives.
  417. National family planning by symptothermic control.
  418. The National Family Planning Coordinating Board of Indonesia.
  419. National fertility survey of El Salvador (FESAL 73): interrelation of absence of sexual relations, contraception, mortality and fertility (5th. part of the analysis) [Encuesta nacional de fecundidad de El Salvador (FESAL-73): interre laciones entreasusencia de relaciones sexuales, aniconcepcion, mortalidad y fecundidad. (Quinta parte del nalisis.)]
  420. National health and family planning.
  421. National levels of natality and birth control. [Niveaux nationaux de la natalite et politiques de limitation des naissances.]
  422. Natural birth control.
  423. Natural family planning and contraceptive technology.
  424. Natural family planning [letter]
  425. Natural family planning.
  426. Natural family planning. (Letter to the editor)
  427. Natural family planning. (Letter to the editor)
  428. Natural family planning. (Letter to the editor)
  429. Natural family planning: (Letter to the editor)
  430. Natural family planning: can it work?
  431. Natural family planning: folly or fulfillment?
  432. Natural family planning: the Billings Method.
  433. Natural methods improved. Hub seminar lauds family planning.
  434. Natural methods of family planning. (Letter to the editor)
  435. NCI begins assessment of oral contraceptives' link with liver tumors.
  436. Near East. (Population policy and family planning)
  437. The need for birth control instruction in the schools. [Om behovet for prevensjonsopplysning i skolen.]
  438. The need for psychosexual counselling in family planning practice.
  439. Nephrosclerosis postpartum and in women taking oral contraceptives.
  440. New approaches to contraception.
  441. New approaches to steroidal contraception.
  442. A new battle in Vietnam. (Family planning)
  443. New centers for information, counseling and family planning. [Les nouveaux organismes d'information de conseil et de planification familiale.]
  444. New combined oral contraceptive with incremental progestogen dosage regimen.
  445. New contraceptive hits U.S. market this month.
  446. New cycle stabilizing contraceptive agent - Ediwal. [Ein neues zyklusstabilisierendes Kontrazeptivum - Ediwal.]
  447. The New Federalism and the provision of subsidized family planning services in Massachusetts.
  448. A new oral contraceptive based on the normophasic method.
  449. New sequential preparations for oral contraception. (Binordiol, Fysioquens, and Sequilarum. [Nogle nye sekvenspraeparater til peroral kontraception. (Binordiol, Fysioquens, og Sequilarum)]
  450. New trends in contraception.
  451. Nigeria: selected studies: social science research for population and family planning policies and programme.
  452. No coercion in family planning: Prime Minister and Health Minister decry rumours.
  453. Non-efficacy of mechanical birth control devices for white-tailed deer.
  454. Nonhyperlipidemic pancreatitis: association with oral contraceptive use. (Abstract only)
  455. Norgestimate: the progestational component of a new combination oral contraceptive. (Abstract only)
  456. Notes on family planning and political power in the Maghreb. [Notes sur planning familial et pouvoir politique au Maghreb.]
  457. Nurse specialists in family planning.
  458. Nurse specialists in family planning. (Letter to the editor)
  459. The nurse's role in family planning services in India.
  460. Nursing and auxiliary personnel: a training guide for family planning programs.
  461. Nutritional effects of oral contraceptives.
  462. Observation on certain evil effects of contraceptive drugs in female virgin albino rats with special reference to cardio-vascular changes. (Abstract only)
  463. Observations on the effect of some oral contraceptive on the ovary of rat. (Abstract only)
  464. On financial management of population and family planning programs.
  465. On the calculation of the probability of current family-planning status in a cohort of women.
  466. One thousand months of contraception with Sulpiride. [Mille mois de contraception par le sulpiride.]
  467. Opening speech (on family planning)
  468. An operational framework for management of comprehensive family planning programs.
  469. An operational framework for management of family planning programmes.
  470. Operations research on household and village contraceptive distribution systems.
  471. Opinion leaders as family planning agents in rural India: a reappraisal.
  472. An optimal contraceptive pill. (A clinical study)
  473. Oral and injectable contraceptives (with appendix on available oral contraceptive products)
  474. Oral and intra-uterine contraceptives: consumption and adverse reactions.
  475. Oral and intrauterine contraceptives: use and adverse reactions. [Oral og intrauterin antikonception.]
  476. Oral contraception and absorption of vitamin B 12. [Oralis contraceptivumok es B 12 vitamin felszivodas.]
  477. Oral contraception and sexuality.
  478. Oral contraception and the endometrium. [Endometre et contraception orale.]
  479. Oral contraception by means of progestagen-only minipills taken continuously in the light of four recent trials. [Le point sur la micropilule progestative en prise continue a la lumiere de quatre experimentations recentes.]
  480. Oral contraception.
  481. Oral contraception. (Letter)
  482. Oral contraception. (Letter)
  483. Oral contraception: thromboembolism and risks of operation. [Hormonale Kontrazeption - Thromboembolie und Operationsrisiko.]
  484. Oral contraceptive failure due to drug interaction. (Letter to the editor.
  485. Oral contraceptive patient information.
  486. Oral contraceptive patient labeling. Part 310 (new drugs) of Subchapter D (drugs for human use) of Chapter 1 (Food and Drug Administration, Department of Health, Education, and Welfare) of Title 21 (Food and Drugs) of the United States Code of Federal Regulations.
  487. Oral contraceptive use in older women and fatal myocardial infarction.
  488. (Oral contraceptive, breakthrough bleeding and pulmonary embolism.)
  489. Oral Contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG.
  490. Oral contraceptive-induced hypertension - nine years later.
  491. Oral contraceptives after 40.
  492. Oral contraceptives after intestinal bypass operations [Letter]
  493. Oral contraceptives and benign liver tumour. (Letter to the editor)
  494. Oral contraceptives and breast neoplasia.
  495. Oral contraceptives and diabetes mellitus.
  496. Oral contraceptives and estrogens for postmenopausal use, 1976. Hearings, January 21, 1976.
  497. Oral contraceptives and ethanol metabolism. (Abstract only)
  498. Oral contraceptives and hypertension. [Orale anticonceptie en hypertensie.]
  499. Oral contraceptives and liver nodules.
  500. Oral contraceptives and liver tumours.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.